Canadian Solar Inc.
CSIQ Nasdaq Semiconductors & Related Devices Financials FY2016–FY2025
Last close · Oct 23, 2026
$9.23
0.1%What Canadian Solar Inc. does
No business description yet.
- Legal name
- Canadian Solar Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F · Apr 10, 2026
- Accession · CIK
- 0001104659-26-041976
0001375877
Revenue and margins
Canadian Solar Inc. had $5.6B of revenue in fiscal 2025, down 6.6% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was −$1.2B in fiscal 2025, −21.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Canadian Solar Inc. returned — to shareholders in fiscal 2025. The diluted share count rose 0.6%.
Balance sheet
Cash, debt and the ratios that show how comfortably Canadian Solar Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $870M | $1,000M | $2.0B | $1.7B | $1.4B |
| Debt incl. finance leases | $2.7B | $3.7B | $5.0B | $6.7B | $8.5B |
| Net debt / EBITDA | 3.8x | 4.6x | 4.1x | 10.5x | 12.0x |
| Debt / equity | 1.5x | 1.9x | 1.9x | 2.3x | 3.0x |
| Interest coverage | 3.3x | 4.8x | 4.0x | −0.2x | 0.2x |
| Current ratio | 1.2x | 1.1x | 1.0x | 1.1x | 1.0x |
| Quick ratio | 0.9x | 0.8x | 0.8x | 0.9x | 0.8x |
| Total assets | $7.4B | $9.0B | $11.9B | $13.5B | $15.2B |
| Total liabilities | $5.3B | $6.7B | $8.2B | $9.4B | $10.9B |
| Shareholders' equity | $1.8B | $1.9B | $2.6B | $2.8B | $2.8B |
| Net debt (− = net cash) | $1.8B | $2.7B | $3.1B | $5.0B | $7.2B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ |
| Cash from operations is positive | ✕ | ✓ | ✓ | ✓ | ✕ | ✕ | ✓ | ✓ | ✕ | ✕ |
| Return on assets rose | — | ✓ | ✓ | ✕ | ✕ | ✕ | ✓ | ✕ | ✕ | ✕ |
| Cash from operations exceeds net income | ✕ | ✓ | ✕ | ✓ | ✕ | ✕ | ✓ | ✓ | ✕ | ✕ |
| Debt fell relative to assets | — | ✕ | ✓ | ✓ | ✓ | ✕ | ✕ | ✕ | ✕ | ✕ |
| Current ratio rose | — | ✕ | ✓ | ✓ | ✓ | ✓ | ✕ | ✕ | ✓ | ✕ |
| Share count didn't rise | — | ✕ | ✕ | ✓ | ✕ | ✕ | ✕ | ✕ | ✓ | ✕ |
| Gross margin rose | — | ✓ | ✓ | ✓ | ✕ | ✕ | ✕ | ✕ | ✕ | ✓ |
| Revenue rose relative to assets | — | ✓ | ✓ | ✕ | ✕ | ✓ | ✓ | ✕ | ✕ | ✕ |
| F-score | — / 3 | 6 / 9 | 7 / 9 | 7 / 9 | 3 / 9 | 3 / 9 | 5 / 9 | 3 / 9 | 3 / 9 | 1 / 9 |
| Accruals ratio | 6.4% | −1.8% | 0.5% | −8.4% | 4.5% | 7.4% | −7.5% | −3.9% | 7.3% | 1.0% |
| Altman Z'' | 0.58 | 0.72 | 1.44 | 1.35 | 1.65 | 1.64 | 1.31 | 1.14 | 0.93 | 0.66 |
10 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.9B | $3.4B | $3.7B | $3.2B | $3.5B | $5.3B | $7.5B | $7.6B | $6.0B | $5.6B |
| Gross profit | $417M | $638M | $775M | $718M | $690M | $909M | $1.3B | $1.3B | $999M | $1.0B |
| Research and development | $17.4M | $28.8M | $44.2M | $47.0M | $45.2M | $58.4M | $69.8M | $101M | $121M | $90.7M |
| Operating income | $93.2M | $269M | $365M | $259M | $220M | $190M | $356M | $453M | −$30.1M | $43.2M |
| Interest expense | $69.7M | $118M | $106M | $81.3M | $71.9M | $58.2M | $74.3M | $114M | $137M | $178M |
| Pretax income | $83.3M | $144M | $304M | $209M | $134M | $138M | $356M | $409M | −$82.3M | −$141M |
| Income tax | $18.0M | $41.0M | $62.0M | $42.1M | −$2.0M | $35.8M | $73.4M | $59.5M | −$16.6M | $14.1M |
| Net income | $65.3M | $103M | $242M | $167M | $147M | $110M | $299M | $274M | $36.1M | −$104M |
| Net income to common | $65.2M | $99.6M | $237M | $172M | $147M | $95.2M | $240M | $274M | $36.1M | — |
| Diluted EPS | $1.12 | $1.69 | $3.88 | $2.83 | $2.38 | $1.46 | $3.44 | $3.87 | $0.54 | −$2.50 |
| Diluted shares | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B |
| Cash flow | ||||||||||
| Cash from operations | −$278M | $204M | $216M | $600M | −$121M | −$408M | $917M | $685M | −$885M | −$253M |
| Capital expenditure | $287M | $277M | $316M | — | — | $429M | $627M | $1.1B | $1.1B | $962M |
| Free cash flow | −$565M | −$73.1M | −$100M | — | — | −$837M | $290M | −$432M | −$2.0B | −$1.2B |
| Depreciation and amortization | $95.8M | $99.3M | $129M | $160M | $209M | $283M | $235M | $307M | $501M | $555M |
| Stock-based compensation | $7.8M | $9.3M | $10.3M | $10.7M | $12.4M | $8.8M | $9.4M | $55.3M | $21.4M | $24.4M |
| Share buybacks | — | — | — | $11.8M | $6.0M | — | — | — | — | — |
| Dividends and buybacks | — | — | — | $11.8M | $6.0M | — | — | — | — | — |
| Balance sheet | ||||||||||
| Cash and short-term investments | $511M | $562M | $444M | $669M | $1.2B | $870M | $1,000M | $2.0B | $1.7B | $1.4B |
| Total debt | $2.8B | $3.1B | $1.9B | $2.0B | $2.1B | $2.6B | $3.7B | $4.9B | $6.5B | $8.4B |
| Finance lease liabilities | — | — | — | $39.1M | $24.3M | $50.2M | $29.1M | $160M | $186M | $142M |
| Current assets | $3.8B | $4.1B | $3.1B | $3.3B | $4.2B | $4.8B | $5.6B | $6.1B | $5.9B | $6.0B |
| Current liabilities | $3.7B | $4.1B | $2.9B | $3.1B | $3.6B | $4.0B | $5.3B | $5.9B | $5.4B | $5.9B |
| Inventory | $295M | $346M | $262M | $554M | $696M | $1.2B | $1.5B | $1.2B | $1.2B | $1.1B |
| Property and equipment, net | $462M | $747M | $885M | $1.0B | $1.2B | $1.4B | $1.8B | $3.1B | $3.2B | $3.4B |
| Goodwill | $7.6M | $6.2M | $1.0M | — | — | — | — | — | — | — |
| Intangible assets | $8.4M | $11.0M | $14.9M | $22.8M | $22.4M | $19.0M | $17.5M | $19.7M | $31.0M | $32.0M |
| Total assets | $5.4B | $5.9B | $4.9B | $5.5B | $6.5B | $7.4B | $9.0B | $11.9B | $13.5B | $15.2B |
| Total liabilities | $4.5B | $4.8B | $3.6B | $4.0B | $4.6B | $5.3B | $6.7B | $8.2B | $9.4B | $10.9B |
| Shareholders' equity | $885M | $1.0B | $1.2B | $1.4B | $1.6B | $1.8B | $1.9B | $2.6B | $2.8B | $2.8B |
| Margins | ||||||||||
| Gross margin | 14.6% | 18.8% | 20.7% | 22.4% | 19.8% | 17.2% | 16.9% | 16.8% | 16.7% | 18.3% |
| Operating margin | 3.3% | 7.9% | 9.7% | 8.1% | 6.3% | 3.6% | 4.8% | 6.0% | −0.5% | 0.8% |
| EBITDA margin | 6.6% | 10.9% | 13.2% | 13.1% | 12.4% | 9.0% | 7.9% | 10.0% | 7.9% | 10.7% |
| Net margin | 2.3% | 3.0% | 6.5% | 5.2% | 4.2% | 2.1% | 4.0% | 3.6% | 0.6% | −1.9% |
| FCF margin | −19.8% | −2.2% | −2.7% | — | — | −15.9% | 3.9% | −5.7% | −33.3% | −21.7% |
| Returns | ||||||||||
| Return on capital | 2.3% | 5.3% | 11.0% | 7.7% | 8.7% | 4.0% | 6.1% | 7.1% | −0.3% | 0.3% |
| Return on capital employed | 5.5% | 15.1% | 18.8% | 10.9% | 7.5% | 5.7% | 9.4% | 7.5% | −0.4% | 0.5% |
| Return on equity | 7.4% | 10.7% | 21.5% | 12.7% | 9.9% | 6.5% | 16.0% | 12.2% | 1.3% | −3.7% |
| Return on assets | 1.2% | 1.8% | 4.5% | 3.2% | 2.5% | 1.6% | 3.6% | 2.6% | 0.3% | −0.7% |
| Return on tangible equity | 7.5% | 9.8% | 19.6% | 12.5% | 9.5% | 5.3% | 12.5% | 10.8% | 1.3% | −3.8% |
| Growth | ||||||||||
| Revenue growth | — | 18.8% | 10.4% | −14.5% | 8.6% | 51.8% | 41.5% | 1.9% | −21.3% | −6.6% |
| Net income growth | — | 57.8% | 135.4% | −31.3% | −11.6% | −25.4% | 171.7% | −8.2% | −86.9% | −388.8% |
| EPS growth | — | 50.9% | 129.6% | −27.1% | −15.9% | −38.7% | 135.6% | 12.5% | −86.0% | −563.0% |
| FCF growth | — | — | — | — | — | — | — | −249.2% | — | — |
| Share count change | — | 6.0% | 1.2% | −2.4% | 2.5% | 10.5% | 3.4% | 1.4% | −7.3% | 0.6% |
| Financial health | ||||||||||
| Net debt / EBITDA | 12.1x | 7.0x | 2.9x | 3.2x | 2.3x | 3.8x | 4.6x | 4.1x | 10.5x | 12.0x |
| Debt / equity | 3.2x | 3.0x | 1.5x | 1.4x | 1.4x | 1.5x | 1.9x | 1.9x | 2.3x | 3.0x |
| Interest coverage | 1.3x | 2.3x | 3.4x | 3.2x | 3.1x | 3.3x | 4.8x | 4.0x | −0.2x | 0.2x |
| Current ratio | 1.0x | 1.0x | 1.0x | 1.1x | 1.2x | 1.2x | 1.1x | 1.0x | 1.1x | 1.0x |
| Quick ratio | 0.9x | 0.9x | 1.0x | 0.9x | 1.0x | 0.9x | 0.8x | 0.8x | 0.9x | 0.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 10.0% | 8.2% | 8.4% | — | — | 8.1% | 8.4% | 14.7% | 18.6% | 17.2% |
| Stock comp / revenue | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% | 0.2% | 0.1% | 0.7% | 0.4% | 0.4% |
| Quality scores | ||||||||||
| Piotroski F-score | — | 6.0 | 7.0 | 7.0 | 3.0 | 3.0 | 5.0 | 3.0 | 3.0 | 1.0 |
| Altman Z'' | 0.6 | 0.7 | 1.4 | 1.3 | 1.7 | 1.6 | 1.3 | 1.1 | 0.9 | 0.7 |
| Accruals ratio | 6.4% | −1.8% | 0.5% | −8.4% | 4.5% | 7.4% | −7.5% | −3.9% | 7.3% | 1.0% |
Source: SEC EDGAR XBRL filings (CIK 0001375877). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
